共查询到20条相似文献，搜索用时 15 毫秒
1.
Lawler A 《Science (New York, N.Y.)》2004,303(5663):1453
2.
3.
4.
Levitt P 《Science (New York, N.Y.)》2004,303(5654):48-49
5.
6.
7.
Vogel G 《Science (New York, N.Y.)》2000,290(5497):1673
As researchers continue to explore the potential uses of stem cells obtained from a variety of sources (see main text), governments around the world are grappling with whether to allow research on stem cells derived from human embryos. Governments are cautious yet increasingly open to the new research, which may eventually yield treatments for a variety of diseases from Parkinson's to diabetes. 相似文献
8.
9.
10.
11.
12.
Enserink M 《Science (New York, N.Y.)》2006,313(5784):160-163
13.
Matthews R 《Science (New York, N.Y.)》2007,318(5854):1232-1233
14.
15.
Holden C 《Science (New York, N.Y.)》2007,315(5813):761
16.
Cancer. Germ cell genes and cancer 总被引：1，自引：0，他引：1
17.
Zerhouni E 《Science (New York, N.Y.)》2003,300(5621):911-912
The availability of human embryonic stem cell lines provides an important tool for scientists to explore the fundamental mechanisms that regulate differentiation into specific cell types. When more is known about the mechanisms that govern these processes, human embryonic stem cells may be clinically useful in generating cell types that have been damaged or depleted by a variety of human diseases. The NIH is actively pursuing a variety of initiatives to promote this developing research field, while continuing and expanding its long-standing investment in adult stem cells and research. 相似文献
18.
Vogel G 《Science (New York, N.Y.)》2001,292(5523):1822
19.
Ranganathan R 《Science (New York, N.Y.)》2007,318(5854):1253-1254